Skip to main content
Equibles

Robert Froman Williamson, III

Board Member

Perspective Therapeutics, Inc. (CATX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Robert Froman Williamson, III

Robert Froman Williamson, III is recorded as Board Member at Perspective Therapeutics, Inc. (CATX). Perspective Therapeutics, Inc. reported in an 8-K filed May 31, 2024 that Robert Froman Williamson, III was appointed Director, effective May 31, 2024. Perspective Therapeutics, Inc. reported in an 8-K filed October 12, 2023 that Robert Froman Williamson, III was appointed Board, effective October 6, 2023. Perspective Therapeutics, Inc. reported in an 8-K filed February 6, 2023 that Robert Froman Williamson, III was appointed director of the Company, effective February 3, 2023.

“The stockholders of the Company elected Lori A. Woods, Heidi Henson, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III to the Board to hold office until the Company’s 2025 Annual Meeting of Stockholders and until his or her successor has been elected and qualified.”
Perspective Therapeutics, Inc. Form 8-K, filed May 31, 2024 · Read the filing
“The stockholders of the Company elected Lori A. Woods, Heidi Henson, Frank Morich, M.D., Ph.D., Johan (Thijs) Spoor and Robert Froman Williamson, III to the Board to hold office until the Company's 2024 Annual Meeting of Stockholders and until his or her successor has been elected and qualified.”
Perspective Therapeutics, Inc. Form 8-K, filed October 12, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Perspective Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.